Search

Author/Creator Keiserman, M.

1. AB0297 Predictors of an inadequate response to treatment in latin american patients with early rheumatoid arthritis. (12th June 2018)

Authors:
Gamboa-Cárdenas, R.V.; Ugarte-Gil, M.; Massardo, L.; Sacnun, M.P.; Granel, A.; Catoggio, L.; Lima-Corrêa, F.A.; Appenzeller, S.; Azevedo, A.; Keiserman, M.; Rueda, J.; Zurita, L.; Moreno, M.; Cardiel, M.; Acevedo-Vasquez, E.; Alarcón, G.S.; Pons-Estel, B.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 77(2018)Supplement 2
Page Start:
1327
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. FRI0193 SC vs IV abatacept in RA: post-hoc efficacy analysis of long-term acquire (SC) data with aim (IV) data. (23rd January 2014)

Authors:
Genovese, M.; Pacheco Tena, C.; Covarrubias Cobos, A.; Leon, G.; Mysler, E.F.; Keiserman, M.; Valente, R.; Nash, P.; Simon Campos, J.A.; Box, J.; Legerton, C.W.; Nasonov, E.; Durez, P.; Delaet, I.; Elegbe, A.; Alten, R.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 71(2012)Supplement 3
Page Start:
378
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. FRI0227 Five-Year Safety and Efficacy of Subcutaneous Abatacept in Patients with Moderate To Severely Active RA and An Inadequate Response To MTX: Long-Term Extension of The Phase III, Double-Blind, Randomized Acquire Study. (15th July 2016)

Authors:
Genovese, M.C.; Pacheco Tena, C.; Covarrubias, A.; Leon, G.; Mysler, E.; Keiserman, M.; Valente, R.; Nash, P.; Simon-Campos, J.A.; Box, J.; Legerton, C.W.; Nasonov, E.; Durez, P.; Elegbe, A.; Wong, R.; Li, X.; Banerjee, S.; Alten, R.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 75(2016)Supplement 2
Page Start:
515
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Long‐Term Safety and Efficacy of Epratuzumab in the Treatment of Moderate‐to‐ Severe Systemic Lupus Erythematosus: Results From an Open‐Label Extension Study. Issue 4 (24th March 2016)

Authors:
Wallace, D. J.; Hobbs, K.; Clowse, M. E. B.; Petri, M.; Strand, V.; Pike, M.; Merrill, J. T.; Leszczyński, P.; Neuwelt, C. M.; Jeka, S.; Houssiau, F.; Keiserman, M.; Ordi‐Ros, J.; Bongardt, S.; Kilgallen, B.; Galateanu, C.; Kalunian, K.; Furie, R.; Gordon, C.
Journal:
Arthritis care & research
Issue:
Volume 68:Issue 4(2016:Apr.)
Page Start:
534
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. OP0223 EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS AND INADEQUATE RESPONSE TO BIOLOGIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS (SELECT-PSA-2): A DOUBLE-BLIND, RANDOMIZED CONTROLLED PHASE 3 TRIAL. (2nd June 2020)

Authors:
Genovese, M. C.; Lertratanakul, A.; Anderson, J.; Papp, K.; Tillett, W.; Van den Bosch, F.; Tsuji, S.; Dokoupilova, E.; Keiserman, M.; Wang, X.; Zhong, S.; Zueger, P.; Pangan, A.; Mease, P. J.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 79(2020)Supplement 1
Page Start:
139
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. SAT0160 EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS FROM CHINA, BRAZIL, AND SOUTH KOREA WITH RHEUMATOID ARTHRITIS WHO HAVE HAD INADEQUATE RESPONSE TO CONVENTIONAL SYNTHETIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS. (2nd June 2020)

Authors:
Zeng, X.; Zhao, D.; Radominski, S.; Keiserman, M.; Lee, C. K.; Meerwein, S.; Enejosa, J.; Sui, Y.; Mohamed, M. E.; Park, W.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 79(2020)Supplement 1
Page Start:
1020
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. SAT0226 Tocilizumab (TCZ) as Combination Therapy and as Monotherapy VS Methotrexate (MTX) in MTX-Naive Patients with Early Rheumatoid Arthritis: Patient-Reported Outcomes (PROS) from A Randomized, Placebo-Controlled Trial. (10th June 2014)

Authors:
Burmester, G.; Blanco, R.; Keiserman, M.; Rigby, W.; van Vollenhoven, R.F.; Dimonaco, S.M.; Grzeschik, S.M.; Mitchell, N.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 73:Supplement 2(2014)
Page Start:
672
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. SAT0281 Impact of enthesitis in 1505 brazilian patients with spondyloarthritis. (23rd January 2014)

Authors:
Carneiro, S.; Bortoluzzo, A.; Gonçalves, C.; Silva, J.A.; Ximenes, A.C.; Bértolo, M.; Ribeiro, S.; Keiserman, M.; Menin, R.; Azevedo, V.; Vieira, W.; Albuquerque, E.; Bianchi, W.; Bonfiglioli, R.; Campanholo, C.; Carvalho, M.A.; Costa, I.; Duarte, A.; Gavi, M.B.; Cohen, C.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 71(2012)Supplement 3
Page Start:
567
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. THU0246 Subcutaneous Abatacept: Long-Term Data From the Acquire Trial. (23rd January 2014)

Authors:
Alten, R.; Pacheco-Tena, C.; Covarrubias, A.; Leon, G.; Mysler, E.; Keiserman, M.; Valente, R.; Nash, P.; Simon-Campos, J.; Box, J.; Legerton, C.; Nasonov, E.; Durez, P.; Delaet, I.; Genovese, M.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 72:Supplement 3(2013)
Page Start:
A248
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. THU0286 Immunologic Response to Long-Term Epratuzumab Treatment in Sl0008, An Open-Label Long-Term Extension Study in Patients with Moderate-to-Severe Systemic Lupus Erythematosus. (23rd January 2014)

Authors:
Strand, V.; Leszczyński, P.; Keiserman, M.; Kilgallen, B.; Bongardt, S.; Wallace, D. J.; Gordon, C.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 72:Supplement 3(2013)
Page Start:
A262
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗